| PPD | packs per day; paraphenylenediamine; percussion and postural drainage; permanent partial disability;... |
|---|---|
| Xan | xanthine |
| XDH | xanthine dehydrogenase |
| XDP | xanthine diphosphate; xeroderma pigmentosum |
| XMP | xanthine monophosphate |
| X-XO | Xanthine-xanthine oxidase |
|---|---|
| BPD | Benzoporphyrin derivative |
| BPD-MA | Benzoporphyrin derivative monoacid ring A |
| EMD | Enamel Matrix Derivative |
| HPD | Haematoporphyrin derivative |
| haematoporphyrin derivative | <chemical> A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumours (haematoporphyrin photoradiation). A purified component of this mixture is known as dihematoporphyrin ether. Pharmacological action: antineoplastic agent, photosensitizing agents. Chemical name: Haematoporphyrin D (12 Dec 1998) |
|---|---|
| purified protein derivative of tuberculin | Purified tuberculin containing the active protein fraction; the tuberculin from which it is prepared differs from tuberculin chiefly in that the bacteria are grown in a synthetic rather than in a broth medium. (05 Mar 2000) |
| derivative | A chemical substance derived from another substance either directly or by modification or partial substitution. (18 Nov 1997) |
| derivative chromosome | An anomalous chromosome generated by translocation. Synonym: translocation chromosome. (05 Mar 2000) |
| methyl xanthine | <chemical, drug> Naturally occurring purine alkaloids such as theobromine, theophylline and caffeine (trimethyl xanthine). They inhibit cAMP phosphodiesterase and thus cause an increase in the intracellular cAMP concentration. (18 Nov 1997) |
| xanthine | <biochemistry> A purine, the starting point for purine degradation. Its methylated derivatives (theophylline, theobromine, caffeine) are potent cAMP phosphodiesterase inhibitors. (18 Nov 1997) |
| xanthine alkaloids | Alkaloids, which contain xanthine as their nitrogenous base. (12 Dec 1998) |
| xanthine bronchodilator | <pharmacology> A group of medications that work by a common mechanism to effect bronchodilation (open up air passages) in the lungs. Used in the treatment of asthma and related conditions. Examples include: theophylline, aminophylline and dyphylline. (27 Sep 1997) |
| xanthine dehydrogenase | <enzyme> An enzyme that catalyses the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. Chemical name: Xanthine:NAD+ oxidoreductase Registry number: EC 1.1.1.204 (12 Dec 1998) |
| xanthine nucleotide | The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis. Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid. (05 Mar 2000) |
| xanthine oxidase | <enzyme> Dehydrogenases involved in conversion of hypoxanthine to xanthine and xanthine to uric acid, as the final catabolism of purines. Deficient in the human disease xanthinuria. (18 Nov 1997) |
| xanthine ribonucleoside | 9-beta-d-ribosylxanthine;the deamination product of guanosine (O replacing -NH2). Synonym: xanthine ribonucleoside. Abbreviation: Xao (05 Mar 2000) |
| hypoxanthine-guanine-xanthine phosphoribosyltransferase | <enzyme> From tritrichomonas foetus; in contrast to EC 2.4.2.8, this enzyme also uses xanthine as substrate; mw 24 kD Registry number: EC 2.4.2.- Synonym: hgxprtase (26 Jun 1999) |
| desulfo xanthine dehydrogenase | <enzyme> Naturally occuring inactive form of xanthine dehydrogenase Registry number: EC 1.1.1.- (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|